Analysts consider Ebos’ result a solid one

Analysts consider Ebos’ result a solid one
Jarden analysts have upgraded their rating for Ebos. (Image: Getty)
Ella Somers
Analysts feel upbeat but cautious about the future after healthcare wholesaler Ebos posted a better-than-expected full-year result on Wednesday.Jarden analysts Adrian Allbon and Nick Yeo upgraded their rating from underweight to neutral for the company.“Underlying cashflows were stronger than expected, with a beat on final dividend and lower net debt versus our expectations,” they wrote.Jarden's other highlights for the company included the LifeHealthcare acquisition performing “in line” with management expectations...

More Markets

Serko: a decade of ups and downs on the NZX
Markets

Serko: a decade of ups and downs on the NZX

The travel tech company that grew through covid.

Infratil's share offer to retailers looks fair
Markets

Infratil's share offer to retailers looks fair

The price and pro-rata offer make it a good opportunity, an analyst says.

NZX 50 ends the week down 1.5% in flurry of index reweighting
Markets Market close

NZX 50 ends the week down 1.5% in flurry of index reweighting

The S&P/NZX 50 index dropped 89.42 points, or 0.8%, to 11,682.39.

Paul McBeth 21 Jun 2024
KMD Brands guidance undershoots analysts' forecasts
Retail

KMD Brands guidance undershoots analysts' forecasts

Group sales between February and May have fallen 8.4% year-on-year.